Lupin Limited Secures U.S. FDA Nod for Glycerol Phenylbutyrate Oral Liquid in Urea Cycle Disorders
Lupin has announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application...
New Meta-Analysis Ranks CAPLYTA®️ Lumateperone First in Efficacy and Metabolic Safety for Adjunctive MDD Treatment
Intra-Cellular Therapies, Inc. announced the presentation of a new network meta-analysis (NMA) demonstrating that CAPLYTA® (lumateperone) showed the greatest improvement across four key efficacy outcomes among...
GloGen Clinical Research Reports USFDA EIR with ‘Closed’ Status Following February Inspection
GloGen Clinical Research Pvt. Ltd. has received the Establishment Inspection Report (EIR) from USFDA, with the determination of “Closed”, auditorium conducted on 09th -13th...
Glenmark Pharmaceuticals Wins U.S. FDA Nod for Generic Progesterone Fertility Therapy
Glenmark Pharmaceuticals has received final approval from the U.S. Food and Drug Administration for its Progesterone Vaginal Inserts, 100 mg, marking a meaningful step forward in expanding...
Dr. Reddy’s Makes History with Health Canada Approval of World’s First Generic Semaglutide Injection in a G7 Market
Dr. Reddy’s Laboratories Ltd.a leading global pharmaceutical company, is pleased to announce it has received a Notice of Compliance (NOC) from Health Canada for...
Union Health Minister J. P. Nadda Reviews NIPER Mohali’s Innovation Pipeline, Inaugurates Medicinal Succulents Garden
Union Minister for Health and Family Welfare and Chemicals & Fertilizers, Shri J. P. Nadda, visited the National Institute of Pharmaceutical Education and Research...
